Rituximab in Treating Patients With Hodgkin's Lymphoma

Clinical trial NCT00003820 · COMPLETED

Trial details

NCT number: NCT00003820
Sponsor: Ranjana Advani
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma Hodgkin Lymphoma (Category)Nodular Lymphocyte Predominant Hodgkin Lymphoma

Start date: 1999-01-01
Primary completion: 2008-08-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.